Growth hormone deficiency screening: Difference between revisions

	Growth hormone deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Growth hormone deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Growth hormone deficiency screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Growth hormone deficiency screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Growth hormone deficiency screening
CDC on Growth hormone deficiency screening
Growth hormone deficiency screening in the news
Blogs on Growth hormone deficiency screening
Directions to Hospitals Treating Growth hormone deficiency
Risk calculators and risk factors for Growth hormone deficiency screening

Revision as of 16:27, 11 August 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Genetic screening

1) early onset of growth failure

2) positive family history and possible consanguinity,

3) height more than 3 sd below the mean

4) extremely low GH response to provocation tests, including GHRH, and very low IGF-I and IGF-binding protein-3 (IGFBP-3) levels.

@@ Line 4: / Line 4: @@
 ==Overview==
+==Screening==
+''Genetic screening''
+) early onset of growth failure
+) positive family history and possible consanguinity,
-*There is insufficient evidence to recommend routine screening for [disease/malignancy].
+) height more than 3 sd below the mean
-OR
-*According to the [guideline name], screening for [disease name] is not recommended.
-OR
-*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
-==Screening==
-*There is insufficient evidence to recommend routine screening for [disease/malignancy].
+) extremely low GH response to provocation tests, including GHRH, and very low IGF-I and IGF-binding protein-3 (IGFBP-3) levels.
-OR
-*According to the [guideline name], screening for [disease name] is not recommended.
-OR
-*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
-**[condition 1]
-**[condition 2]
-**[condition 3]
 ==References==